MacroGenics, Inc.
MGNX
$4.11
-$0.21-4.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.70% | -13.69% | -14.66% | -24.92% | 251.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.70% | -13.69% | -14.66% | -24.92% | 251.00% |
| Cost of Revenue | -3.07% | -9.33% | -10.88% | -12.18% | -8.94% |
| Gross Profit | 63.44% | -10.11% | -3.46% | -22.94% | 83.66% |
| SG&A Expenses | -40.66% | -43.10% | -44.88% | 3.48% | 14.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.23% | -18.46% | -20.15% | -8.66% | -3.61% |
| Operating Income | 46.89% | 25.50% | 27.60% | -12.80% | 56.68% |
| Income Before Tax | -156.18% | -47.47% | -24.97% | 15.94% | 68.79% |
| Income Tax Expenses | -174.07% | -171.19% | -171.19% | -- | -- |
| Earnings from Continuing Operations | -148.24% | -43.82% | -22.21% | 14.87% | 68.02% |
| Earnings from Discontinued Operations | 1,198.06% | 1,363.38% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.91% | -26.06% | -11.43% | 22.26% | 73.31% |
| EBIT | 46.89% | 25.50% | 27.60% | -12.80% | 56.68% |
| EBITDA | 49.29% | 27.14% | 29.26% | -13.61% | 58.96% |
| EPS Basic | 59.87% | -25.14% | -10.17% | 23.28% | 73.73% |
| Normalized Basic EPS | 29.05% | 11.41% | 20.06% | -19.67% | 42.85% |
| EPS Diluted | 59.73% | -23.72% | -10.38% | 22.82% | 73.35% |
| Normalized Diluted EPS | 29.13% | 11.49% | 20.12% | -19.56% | 42.80% |
| Average Basic Shares Outstanding | 0.77% | 0.77% | 0.85% | 0.95% | 1.07% |
| Average Diluted Shares Outstanding | 0.74% | 0.75% | 0.82% | 0.92% | 1.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |